Investor FAQs
Trevi Therapeutics, 195 Church Street, 14th Floor, New Haven, CT 06510. Phone: 203-304-2499
For investor-related questions, please visit “Investor Contacts” under the “Investor Resources” section of our corporate website.
The Company was founded in 2011.
Delaware.
Trevi Therapeutics’ common stock began trading on the Nasdaq Global Market on May 7, 2019.
Trevi Therapeutics’ common stock is listed on the NASDAQ Global Market under the symbol “TRVI”.
The transfer agent and registrar for the common stock of Trevi Therapeutics, Inc. stock is
Computershare Trust Company, N.A.
Regular Delivery:
Computershare
P.O. Box 43006
Providence RI 02940-3006
By Overnight Delivery:
Computershare
150 Royall St., Suite 101
Canton, MA 02021
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
Online: Computershare Investor Services, https://www-us.computershare.com/investor/Contact Phone: (800) 736-3001 (US, Canada, Puerto Rico); (781) 575-3100 (non-US)
Email: web.queries@computershare.com
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare, 150 Royall St., Suite 101, Canton, MA 02021.
To replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A. The transfer agent can look up your records and make any necessary adjustments.
The Company does not have a direct stock purchase plan.
Ernst & Young LLP, Hartford, CT.
December 31st.
Please visit our webpage at www.trevitherapeutics.com.
The press release archive can be viewed on the “Press Releases” section under the “Investors” tab, and financial reports are available under the “SEC Filings” page under the “Investors” tab located at our website www.trevitherapeutics.com.
Trevi Therapeutics, Inc.’s SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” page under the “Investors” tab located at our website www.trevitherapeutics.com.
Please access the “Investor Alerts” page to be notified of Company press releases and other information.
Please visit the “About” section on our website at www.trevitherapeutics.com.
Copies of Trevi Therapeutics, Inc.’s annual report and proxy can be found on www.sec.gov and are also available under the “SEC Filings” page under the “Investors” tab located at our website www.trevitherapeutics.com.